van Vugt HA - Search Results

1

Compliance with biopsy recommendations of a prostate cancer risk calculator.

van Vugt HA, Roobol MJ, Busstra M, Kil P, Oomens EH, de Jong IJ, Bangma CH, Steyerberg EW, Korfage I. van Vugt HA, et al. BJU Int. 2012 May;109(10):1480-8. doi: 10.1111/j.1464-410X.2011.10611.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933335 Clinical Trial.

2

The implementation of screening for prostate cancer.

van Leeuwen PJ, van Vugt HA, Bangma CH. van Leeuwen PJ, et al. Among authors: van vugt ha. Prostate Cancer Prostatic Dis. 2010 Sep;13(3):218-27. doi: 10.1038/pcan.2010.14. Epub 2010 Aug 3. Prostate Cancer Prostatic Dis. 2010. PMID: 20680029 Review.

3

Disease insight and treatment perception of men on active surveillance for early prostate cancer.

van den Bergh RC, van Vugt HA, Korfage IJ, Steyerberg EW, Roobol MJ, Schröder FH, Essink-Bot ML. van den Bergh RC, et al. Among authors: van vugt ha. BJU Int. 2010 Feb;105(3):322-8. doi: 10.1111/j.1464-410X.2009.08764.x. Epub 2009 Jul 7. BJU Int. 2010. PMID: 19594731

4

Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.

van Vugt HA, Roobol MJ, Venderbos LD, Joosten-van Zwanenburg E, Essink-Bot ML, Steyerberg EW, Bangma CH, Korfage IJ. van Vugt HA, et al. Eur J Cancer. 2010 Feb;46(3):669-77. doi: 10.1016/j.ejca.2009.11.022. Eur J Cancer. 2010. PMID: 20022239

5

Should prostate-specific antigen screening be offered to asymptomatic men?

van Vugt HA, Bangma CH, Roobol MJ. van Vugt HA, et al. Expert Rev Anticancer Ther. 2010 Jul;10(7):1043-53. doi: 10.1586/era.10.64. Expert Rev Anticancer Ther. 2010. PMID: 20645694 Review.

6

Prediction of prostate cancer in unscreened men: external validation of a risk calculator.

van Vugt HA, Roobol MJ, Kranse R, Määttänen L, Finne P, Hugosson J, Bangma CH, Schröder FH, Steyerberg EW. van Vugt HA, et al. Eur J Cancer. 2011 Apr;47(6):903-9. doi: 10.1016/j.ejca.2010.11.012. Epub 2010 Dec 14. Eur J Cancer. 2011. PMID: 21163642

7

Updating the prostate cancer risk indicator for contemporary biopsy schemes.

Bul M, Delongchamps NB, Steyerberg EW, de la Roza G, van Leeuwen PJ, Zhu X, van Vugt HA, Haas GP, Schröder FH, Roobol MJ. Bul M, et al. Among authors: van vugt ha, van leeuwen pj. Can J Urol. 2011 Apr;18(2):5625-9. Can J Urol. 2011. PMID: 21504651

8

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.

Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, Schröder FH. Roobol MJ, et al. Among authors: van vugt ha, van leenders ag. Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15. Eur Urol. 2012. PMID: 22104592

9

Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.

van Vugt HA, Roobol MJ, van der Poel HG, van Muilekom EH, Busstra M, Kil P, Oomens EH, Leliveld A, Bangma CH, Korfage I, Steyerberg EW. van Vugt HA, et al. Among authors: van der poel hg, van muilekom eh. BJU Int. 2012 Jul;110(2):180-7. doi: 10.1111/j.1464-410X.2011.10679.x. Epub 2011 Nov 23. BJU Int. 2012. PMID: 22112199

10

Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort.

van Vugt HA, Kranse R, Steyerberg EW, van der Poel HG, Busstra M, Kil P, Oomens EH, de Jong IJ, Bangma CH, Roobol MJ. van Vugt HA, et al. Eur J Cancer. 2012 Aug;48(12):1809-15. doi: 10.1016/j.ejca.2012.02.002. Epub 2012 Mar 7. Eur J Cancer. 2012. PMID: 22406050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters